JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2017, Vol. 55 ›› Issue (4): 55-59.doi: 10.6040/j.issn.1671-7554.0.2016.1285

Previous Articles     Next Articles

Clinical value of PNI and HGB in evaluating the prognosis of the middle to late stage non-small cell lung cancer patients

SUN Qijing1, CHEN Fangfang2, LI Chunxiao3, ZHANG Caiqing2   

  1. 1. Medical College of Shandong University, Jinan 250012, Shandong, China;
    2. Respiratory Physicians of Qianfoshan Hospital Affiliated to Shandong University, Jinan 250014, Shandong, China;
    3. Medical College of Taishan, Taian 271000, Shandong, China
  • Received:2016-10-11 Online:2017-04-10 Published:2017-04-10

PDF (PC)

353

Abstract: Objective To explore the clinical value of prognosis of nutrition index(PNI)and hemoglobin(HGB)in evaluating the prognosis of the middle to late stage non-small cell lung cancer patients. Methods A total of 120 cases of the middle to late stage non-small cell lung cancer patients were selected during August 2013 and August 2015. The clinical information and data of all patients were collected when they were first confirmed. All patients were followed-up by the date of death or August 2016 through electronic medical record system, outpatient and telephone, etc. The patients were divided into high and low PNI groups, and high and low HGB groups on the basis of the medians of PNI(46.52)and HGB(115 g/L). The impact of PNI and HGB on overall survival(OS)of patients was analyzed through single factor and multiple factors methods. The survival curves of two groups were produced by Kaplan-Meier method. The Log-rank test was exerted. The related influencing factors of PNI and HGB were analyzed through single factor method. Results The single factor analysis showed that the patients with age≥65 years, smoking index≥400, PNI<46.52, HGB<115 g/L when they were first confirmed had significantly lower OS than those with age<65 years, 山 东 大 学 学 报 (医 学 版)55卷4期 -孙启晶,等.PNI及HGB评估中晚期非小细胞肺癌患者预后的临床价值 \=-smoking index<400, PNI≥46.52, HGB≥115 g/L(P<0.05). PNI were closely related to the age, clinical stages, pleural effusion and smoking index(P<0.05). HGB were closely related to the age and weight loss rate(P<0.05). The multiple factors analysis showed that only PNI and HGB were statistically significant on OS of the patients［Exp(B)=2.180, P<0.001; Exp(B)=2.032, P=0.001］. The survival curves and Log-rank test showed that low PNI and HGB groups had lower OS than high PNI and HGB groups(P<0.001). Conclusion PNI and HGB can be used as the independent risk factors for the middle to late stage non-small cell lung cancer patients.

Key words: Risk factors, Prognosis of nutrition index, Hemoglobin, Non-small cell lung cancer, Prognostic

CLC Number: 

  • R734
[1] Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013[J]. CA Cancer J Clin, 2013, 63(1): 11-30.
[2] Jones CD, Cummings IG, Shipolini AR, et al. Does surgery improveprognosis in patients with small-cell lung carcinoma?[J]. Interact Cardiovasc Thorac Surg, 2013, 16(3): 375-380.
[3] Tartari RF, Ulbrich-Kulczynski JM, Filho AF. Measurement of mid-arm muscle circumference and prognosis in stage Ⅳnon-small cell lung cancer patients[J]. Oncol Lett, 2013, 5(3): 1063-1067.
[4] Onodera T, Goseki N, Kosaki G. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients[J]. Nihon Geka Gakkai Zasshi, 1984, 85(9): 1001-1005.
[5] Yao ZH, Tian GY, Wan YY, et al. Prognostic nutritional index predicts outcomes of malignantpleural mesothelioma[J]. Cancer Res Clin Oncol, 2013, 139(12): 2117-2123.
[6] Wigren T, Oksanen H, Kellokumpu-Lehtinen P. A practical prognostic index for inoperable non-small-cell lung cancer[J]. Cancer Res Clin Oncol, 1997, 123(5): 259-266.
[7] Harrison LB, Chadha M, Hill RJ, et al. Impact of tumor hypoxia and anemia on radiation therapy outcomes[J]. Oncologist, 2002, 7(6): 492-508.
[8] Migita K, Takayama T, Saeki K, et al. The prognostic nutritional index predicts long-term outcomes of gastric cancer patients independent of tumor stage[J]. Ann Surg Oncol, 2013, 20(8): 2647-2654.
[9] 钱桂生.肺癌不同病理类型发病率的变化情况及其原因[J].中华肺部疾病杂志(电子版), 2011, 4(1): 1-6. QIAN Guisheng. The incidence and reasons for the changes of different pathological types of lung cancer[J]. Clin J Lung Dis(Electronic Edition), 2011, 4(1): 1-6.
[10] de Marinis F, Rossi A, Di Maio M, et al. Treatment of advanced non-small-cell lung cancer: Italian Association of Thoracic Oncology(AIOT)clinical practice guidelines[J]. Lung Cancer, 2011, 73(1): 1-10.
[11] Crinò L, Weder W, van Meerbeeck J, et al. ESMO Guidelines Working Group: early stage and locally advanced(non-metastatic)non-small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Ann Oncol, 2010, 7(21): v103- v115.
[12] Jemal A, Bray F, Center MM, et al. Global cancerstatistics[J]. CA Cancer J Clin, 2011, 61(2): 69-90.
[13] Alexiou C, Onyeaka CV, Beggs D, et al. Do women live longer followinglung resection for carcinoma?[J]. Eur J Cardiothorac Surg, 2002, 21(2): 319-325.
[14] Coussens LM, Werb Z. Inflammation and cancer[J]. Nature, 2002, 420(6917): 860-867.
[15] Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation[J]. Nature, 2008, 454(7203): 436-444.
[16] Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operative cancer[J]. Future Oncol, 2010, 6(1): 149-163.
[17] Proctor MJ, Morrison DS, Talwar D, et al. A Glasgow inflammation outcome study[J]. Eur J Cancer, 2011, 47(17): 2633-2641.
[18] Qiu C, Qu X, Shen H, et al. Evaluation of prognostic nutritional index in patients undergoing radical surgery with nonsmall cell lung cancer[J]. Nutr Cancer, 2015, 67(5): 741-747.
[19] Chamogeorgakis T, Anagnostopoulos C, Kostopanagiotou G, et al. Does anemia affect outcome after lobectomy or pneumonectomy in early stage lung cancer patients who have not received neo-adjuvant treatment?[J]. Thorac Cardiovasc Surg, 2008, 56(3): 148-153.
[20] Tomita M, Shimizu T, Hara M, et al. Impact of preoperative hemoglobin level on survival of non-small cell lungcancer patients[J]. Anticancer Res, 2008, 28(3): 1947-1950.
[21] MacRae R, Shyr Y, Johnson D, et al. Declining hemoglobinduring chemoradiotherapy for locally advanced non-small celllung cancer is significant[J]. Radiother Oncol, 2002, 64(1): 37-40.
[22] Hsu CL, Chen KY, Shih JY, et al. Advanced non-small cell lung cancer in patients aged 45 years or younger: outcome and prognostic factors[J]. BMC Cancer, 2012, 12: 241.
[23] Merlini L, Carteni G, Iacobelli S, et al. Anemia prevalence and treatment practice in patients with non-myeloid tumors receiving chemotherapy[J]. Cancer Manag Res, 2013, 2(5): 205-214.
[24] 郝静,王秀问,蔡毅然,等.在非小细胞肺癌中急、慢性乏氧标记物HIF-1α、GLUT1表达的临床意义[J].山东大学学报(医学版),2005,43(8): 756-759. HAO Jing, WANG Xiuwen, CAI Yiran, et al. Expressions of HIF-1α and GLUT1 and their clinical significance in non-small cell lung cancer[J]. Journal of Shandong University(Healthy Sciences), 2005, 43(8): 756-759.
[25] Calabrich A, Katz A. Management of anemia in cancer patients[J]. Future Oncol, 2011, 7(4): 507-517.
[1] PENG Yue, FENG Zhen, XIE Hounai, WANG Hui, LI Meng, REN Wangang, LIU Tong, PENG Zhongmin. Surgical treatment for 61 patients with multiple lung lesions [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(11): 42-46.
[2] DU Heng, YUAN Xiaodong. Progress in the etiology and pathogenesis of Alzheimers disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 21-27.
[3] QIU Chengxuan, DU Yifeng. A call for action to strengthen research on population interventions against Alzheimers disease and senile dementia [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 1-6.
[4] WANG Lili, HUO Bin, WANG Lei, WANG Hao, HOU Dingkun, HUO Xiaodong, WANG Jinhuan, ZANG Li, CAO Qiang, CHAI Shude, WANG Haitao. Meta-analysis and system evaluation of 125I implantation in the treatment of early lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 76-83.
[5] WANG Yihua, MA Lin, KAN Yanmin, WANG Wentao. Early ultrasound observation of uterine incision defect after cesarean section and analysis of related factors [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(5): 39-44.
[6] GAO Ang, WANG Shijiang, FU Zheng, SUN Xindong, YU Jinming, MENG Xue. A feasibility study for boost target delineation using 18F-FDG PET/CT in local advanced non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(7): 73-77.
[7] YANG Shengsi, CHENG Yufeng. Application of Onodera prognostic nutrition index in elderly patients with esophageal carcinoma treated with radiotherapy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(6): 54-57.
[8] HAN Yunfeng, XU Hua, LIU Qian, SUN Hanchen, XU Dandan, HOU Weikai, HUANG Qingxian. Effect of blood glucose on expressions of GLUT1 and GLUT4 mRNA in myocardial tissues of diabetic rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(5): 27-30.
[9] YANG Lu, LIU Yanguo, LI Jisheng, WANG Xiuwen. Effect of bufalin on chemosensitivity to cisplatin in non-small cell lung cancer and the underlying mechanisms [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(3): 6-11.
[10] GAO Peng, SHEN Fangzhen, XIAO Wenjing, XIU Yuande, ZHOU Lingling. Correlation between the expressions of Runx2 and Ezrin and postoperative metastasis in patients with stage IB non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(1): 63-66.
[11] YUAN Zhiping, MOU Huaping, CHEN Jialian, DENG Li. Expressions and significances of serum hepatic cancer-derived growth factor and vascular endothelial growth factor in patients with non-small cell lung cancer [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(9): 63-66.
[12] ZHANG Zhimian1, PU Huaqing1, WANG Bingxiang2. Research progress on the secretory and analgesic effects of erythrocytes [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(5): 1-4.
[13] ZHANG Ying, CHEN Hongmei, WU Xinyi. Prevalence and risk factors of dry eye syndrome in senior high school students in Shouguang City of Shandong Province, China [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(3): 82-85.
[14] CHEN Xianghong, LIU Yan, WENG Yuxin, KANG Wenjuan, YANG Shibing. Hypoglycemic mechanism of volatile oil of plateau plant Brassica rapa L. in hyperlipidemic and hyperglycemic mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(12): 20-23.
[15] GUO Ya-di, GAO Yan-yan, LI Li, SUN Rui-xia, WANG Jing, XIAN Yu-xin. Effects of lansoprazole therapy on the plasma glucose and gastrin in the patients with type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(7): 62-66.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd